Sobi, Inc. Leadership

Rami Levin

President, North America

Employed since January 2014. MBA - Rekanati Business School, Tel-Aviv University, Israel . BSc in Biology - Tel-Aviv University, Israel. Over 18 years of experience in the pharmaceutical industry in a variety of Marketing, Sales and General Management leadership roles in different countries.

Previous positions: Various senior positions within Merck Serono since 1998, most recently as Vice President of Marketing (US) 2012-2014. Managing Director Scandinavia (Sweden) 2008-2012. Global Marketing Head (Switzerland) 2001-2008. Business Unit Manager (Israel) 1998-2001. Product Manager, Schering AG (Israel) 1996-1998.

Christine Belin

Vice President, Finance, North America

Employed since September 2014. MBA- Johnson Graduate School of Management at Cornell University, BS in Chemical Engineering from Cornell University. Over 15 years of experience in the pharmaceutical industry in a variety of finance leadership roles.

Previous positions: Director of Finance and Revenue Accounting at Ariad Pharmaceuticals 2013-2014, Director of Commercial Financial Planning and Analysis at Human Genome Sciences 2010-2013, and various positions at Amgen from 2002 through 2010 including Director of Finance for Colorado Operations 2007-2010 and Senior Finance Manager of Europe R&D at Amgen, Ltd in Cambridge, UK 2005-2007. Before Amgen, she worked as a reservoir engineer at Shell Exploration and Production Co.

Matthew Boyd

Vice President, Head of Regulatory Affairs, North America

Employed since September 2014. MBA - Indiana University, Kelley School of Business, B.Sc. in Pharmacy - University of the Sciences, Philadelphia College of Pharmacy.

Previous positions: Various positions within Merck Serono since 2005, most recently asDirector of Digital and Social Media, Global Marketing Excellence (2012-2014). Director US Regulatory Affairs (2009-2012). Director US Regulatory Affairs, Sanofi (US) 2005-2009. Associate Director Global Promotion Compliance and Labeling, Bristol-Myers Squibb (US) 2001-2005.

Scott Brewster

Vice President, Head of Operations and Patient Access, North America

Employed since October 2009. B.A. in American Studies from Washington College. Over 25 years of experience in the pharmaceutical/biotech industry in a variety of leadership roles ranging from Sales, Reimbursement, Logistics, Government Affairs to Patient Access.

Previous positions: Various senior level positions within Start-up biotech organizations and large pharmaceutical companies throughout North America, most recently at SOBI, Inc as Director of Reimbursement and Logistics, N.A. 2009-2014. Corporate Account Director at Inspire Pharmaceuticals (US) 2007-2009. Government Account Director (US) Encysive Pharmceuticals 2005-2007. 

Heather Golding

Vice President, Head of Legal and Compliance, North America

Employed since November 2015. J.D. – University of Connecticut School of Law. B.A. –International Studies, Colby College. Over 10 years of experience providing legal and compliance guidance to the pharmaceutical industry. 

Previous positions: Director, Legal and Compliance at Takeda Oncology (formerly Millennium Pharmaceuticals) (2013-2015); Assoc. Director, Corporate Compliance at Takeda Oncology (2011-2013). Associate, Government Enforcement and Compliance Practice Group at Choate, Hall & Stewart LLP (2005-2011). Special Assistant District Attorney, Suffolk County, MA (2010). 

Mike Keavany

Vice President, Sales and Marketing

Employed since September 2014. Over 30 years of experience in the pharmaceutical/biotech industry in a variety of leadership roles in sales, marketing, managed markets, and patient support services. Focused on Rare/Specialty diseases for the past 20 years.

Previous positions: Senior Sales and Marketing positions with Synageva, Inspiration, CSL Behring, Praecis, Wyeth and Genetics Institute. Early career with Zeneca in a variety of positions. 

Bob McLay

General Manager, Canada

Bob McLay

Employed since February, 2016. MBA – Auburn University, Auburn Alabama. BSc – University of Guelph, Guelph, Ontario. Over 23 years of experience in the pharmaceutical industry with multiple leadership roles in marketing, sales, patient access, supply chain, trade relations and business development.

Previous Positions: Multiple senior level positions with both large and small pharmaceutical companies. Most recently, VP Sales and Marketing & Canadian Commercial Lead at Merus Labs International (2014-2015), Director of Sales at Takeda Canada (2012-2013), Marketing Director at Graceway Pharmaceuticals (2007-2012), Associate Sales Director and other various sales and marketing roles at Pfizer Canada (1994-2007).

Sarah O’Brien

Vice President, Human Resources, North America

Employed since July of 2016.  Early career in Finance with a shift to Human Resources across the investment banking and pharmaceutical industry.  HR leadership roles span business partner, organizational development, compensation and benefits areas of focus.

Previous Positions:  Global Human Resources Director, Oncology & Immuno-oncology and Site Head, Human Resources Emeryville, CA at the Novartis Institute for BioMedical Research; Head of Compensation & Benefits at Novartis Vaccines & Diagnostics and various HR roles with Nationwide Insurance, Mellon Capital Management and Bank of New York Mellon.

Len Walt

Vice President, Head of Medical Affairs, North America

Employed since March 2015, M.D - Univ. of Witwatersrand, Johannesburg MBA - Univ. of Cape Town .Over 25 years experience in the biotechnology and pharmaceutical industries in a variety of Medical Affairs roles.

Previous positions: Global Medical Director, Sobi (2015-2016), Medical Director Canada, Sobi (2015), Medical Director at Biogen Idec Canada (2006 -2015), Vice-President Research & Development at Sanofi-Synthelabo Canada (2000 - 2004) and Vice-President Research and Development at Glycodesign Inc (1999 - 2000),  Medical Director at Hoffman La Roche Canada (1996 - 1999), Medical Advisor at Glaxo Wellcome Canada (1993 - 1996) and  Medical Director at Hoechst South Africa (1991 - 1992).